(2022). $60.7 Million Worldwide Bioprocess Validation Industry to 2027 - Featuring Merck, Pall, Sartorius Stedim Biotech, SGS and Eurofins Scientific Among Others. M2PressWIRE.
Chicago Style (17th ed.) Citation"$60.7 Million Worldwide Bioprocess Validation Industry to 2027 - Featuring Merck, Pall, Sartorius Stedim Biotech, SGS and Eurofins Scientific Among Others." M2PressWIRE 2022.
MLA (9th ed.) Citation"$60.7 Million Worldwide Bioprocess Validation Industry to 2027 - Featuring Merck, Pall, Sartorius Stedim Biotech, SGS and Eurofins Scientific Among Others." M2PressWIRE, 2022.
Warning: These citations may not always be 100% accurate.
